These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8480584)

  • 1. 31P MR spectroscopy in hypertrophic cardiomyopathy: comparison with Tl-201 myocardial perfusion imaging.
    Sakuma H; Takeda K; Tagami T; Nakagawa T; Okamoto S; Konishi T; Nakano T
    Am Heart J; 1993 May; 125(5 Pt 1):1323-8. PubMed ID: 8480584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy.
    Sieverding L; Jung WI; Breuer J; Widmaier S; Staubert A; van Erckelens F; Schmidt O; Bunse M; Hoess T; Lutz O; Dietze GJ; Apitz J
    Am J Cardiol; 1997 Aug; 80(3A):34A-40A. PubMed ID: 9293954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring inorganic phosphate and intracellular pH in the healthy and hypertrophic cardiomyopathy hearts by in vivo 7T
    Valkovič L; Clarke WT; Schmid AI; Raman B; Ellis J; Watkins H; Robson MD; Neubauer S; Rodgers CT
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):19. PubMed ID: 30871562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
    Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of abnormal high signal intensity of left ventricular myocardium by gadolinium-diethylenetriaminepenta-acetic acid enhanced magnetic resonance imaging in hypertrophic cardiomyopathy].
    Koito H; Suzuki J; Nakamori H; Ohkubo N; Wakayama Y; Iwasaka T; Inada M; Katoh T
    J Cardiol; 1995 Apr; 25(4):163-70. PubMed ID: 7752050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy.
    Jung WI; Sieverding L; Breuer J; Schmidt O; Widmaier S; Bunse M; van Erckelens F; Apitz J; Dietze GJ; Lutz O
    J Magn Reson; 1998 Jul; 133(1):232-5. PubMed ID: 9654494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy.
    de Roos A; Doornbos J; Luyten PR; Oosterwaal LJ; van der Wall EE; den Hollander JA
    J Magn Reson Imaging; 1992; 2(6):711-9. PubMed ID: 1446116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
    Auffermann W; Chew WM; Wolfe CL; Tavares NJ; Parmley WW; Semelka RC; Donnelly T; Chatterjee K; Higgins CB
    Radiology; 1991 Apr; 179(1):253-9. PubMed ID: 2006287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
    Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
    J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise.
    Yabe T; Mitsunami K; Okada M; Morikawa S; Inubushi T; Kinoshita M
    Circulation; 1994 Apr; 89(4):1709-16. PubMed ID: 8149536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
    Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
    Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
    Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
    J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
    Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
    Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS.
    Okada M; Mitsunami K; Inubushi T; Kinoshita M
    Magn Reson Med; 1998 May; 39(5):772-82. PubMed ID: 9581609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
    Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
    Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy.
    Yabe T; Mitsunami K; Inubushi T; Kinoshita M
    Circulation; 1995 Jul; 92(1):15-23. PubMed ID: 7788910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
    Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
    Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy.
    Jung WI; Sieverding L; Breuer J; Hoess T; Widmaier S; Schmidt O; Bunse M; van Erckelens F; Apitz J; Lutz O; Dietze GJ
    Circulation; 1998 Jun; 97(25):2536-42. PubMed ID: 9657474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
    Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
    Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.